 Jeniann Yi
Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 10 | 2025 | 384 | 2.620 |
Why?
| | Vascular Surgical Procedures | 8 | 2023 | 339 | 2.610 |
Why?
| | Blood Vessel Prosthesis Implantation | 6 | 2025 | 228 | 2.390 |
Why?
| | Operating Rooms | 3 | 2025 | 146 | 2.080 |
Why?
| | Electronic Health Records | 5 | 2025 | 1173 | 1.970 |
Why?
| | Workflow | 4 | 2025 | 184 | 1.960 |
Why?
| | Aortic Aneurysm, Thoracic | 3 | 2025 | 139 | 1.530 |
Why?
| | Kidney Failure, Chronic | 2 | 2023 | 598 | 0.940 |
Why?
| | Carotid Stenosis | 2 | 2024 | 102 | 0.940 |
Why?
| | Health Information Systems | 1 | 2025 | 16 | 0.940 |
Why?
| | Aortic Aneurysm, Abdominal | 2 | 2024 | 167 | 0.910 |
Why?
| | Meaningful Use | 1 | 2024 | 13 | 0.860 |
Why?
| | Peripheral Vascular Diseases | 2 | 2022 | 104 | 0.860 |
Why?
| | Incisional Hernia | 1 | 2024 | 3 | 0.850 |
Why?
| | Efficiency, Organizational | 2 | 2025 | 139 | 0.840 |
Why?
| | Sexism | 2 | 2023 | 70 | 0.840 |
Why?
| | Thrombosis | 3 | 2023 | 393 | 0.810 |
Why?
| | Pandemics | 4 | 2022 | 1694 | 0.780 |
Why?
| | Racism | 2 | 2023 | 151 | 0.740 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 94 | 0.730 |
Why?
| | Congresses as Topic | 1 | 2023 | 221 | 0.720 |
Why?
| | Spinal Cord Ischemia | 1 | 2022 | 60 | 0.700 |
Why?
| | Referral and Consultation | 2 | 2025 | 851 | 0.700 |
Why?
| | Salaries and Fringe Benefits | 1 | 2021 | 60 | 0.680 |
Why?
| | Renal Dialysis | 3 | 2023 | 462 | 0.670 |
Why?
| | Surgeons | 3 | 2023 | 339 | 0.670 |
Why?
| | Cost Savings | 1 | 2021 | 86 | 0.670 |
Why?
| | Medical Informatics | 1 | 2021 | 97 | 0.640 |
Why?
| | Physicians, Women | 1 | 2021 | 88 | 0.630 |
Why?
| | Personnel Selection | 1 | 2021 | 93 | 0.620 |
Why?
| | Treatment Outcome | 16 | 2025 | 11679 | 0.620 |
Why?
| | Stents | 5 | 2024 | 556 | 0.610 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 291 | 0.590 |
Why?
| | Administrative Claims, Healthcare | 1 | 2018 | 28 | 0.560 |
Why?
| | Hospital Charges | 1 | 2018 | 46 | 0.560 |
Why?
| | Peripheral Arterial Disease | 2 | 2022 | 503 | 0.540 |
Why?
| | Reimbursement Mechanisms | 1 | 2018 | 80 | 0.540 |
Why?
| | Stroke | 3 | 2024 | 1256 | 0.530 |
Why?
| | Quality Improvement | 3 | 2022 | 1289 | 0.510 |
Why?
| | Thoracic Outlet Syndrome | 1 | 2016 | 14 | 0.510 |
Why?
| | Ribs | 1 | 2016 | 35 | 0.500 |
Why?
| | Osteotomy | 2 | 2018 | 127 | 0.490 |
Why?
| | Incidental Findings | 1 | 2016 | 80 | 0.480 |
Why?
| | Research Design | 1 | 2022 | 1135 | 0.480 |
Why?
| | Vascular Malformations | 1 | 2016 | 50 | 0.480 |
Why?
| | Lymph | 1 | 2015 | 31 | 0.450 |
Why?
| | Humans | 39 | 2025 | 144759 | 0.450 |
Why?
| | Health Care Costs | 1 | 2018 | 427 | 0.440 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 96 | 0.440 |
Why?
| | Median Arcuate Ligament Syndrome | 2 | 2025 | 8 | 0.420 |
Why?
| | Time Factors | 7 | 2025 | 7173 | 0.420 |
Why?
| | Risk Factors | 9 | 2025 | 10779 | 0.400 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 201 | 0.380 |
Why?
| | Retrospective Studies | 11 | 2025 | 17066 | 0.370 |
Why?
| | Adenocarcinoma | 2 | 2020 | 928 | 0.320 |
Why?
| | Risk Assessment | 5 | 2025 | 3671 | 0.280 |
Why?
| | United States | 8 | 2025 | 15966 | 0.280 |
Why?
| | Patient Readmission | 2 | 2025 | 758 | 0.280 |
Why?
| | Celiac Artery | 2 | 2025 | 20 | 0.280 |
Why?
| | Sex Factors | 2 | 2023 | 2112 | 0.240 |
Why?
| | Female | 16 | 2025 | 78271 | 0.240 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 586 | 0.240 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2730 | 0.240 |
Why?
| | Databases, Factual | 4 | 2025 | 1486 | 0.230 |
Why?
| | Male | 12 | 2025 | 72315 | 0.220 |
Why?
| | Postoperative Hemorrhage | 2 | 2016 | 104 | 0.220 |
Why?
| | Colorectal Neoplasms | 1 | 2012 | 845 | 0.210 |
Why?
| | Lithotripsy | 1 | 2024 | 49 | 0.200 |
Why?
| | Middle Aged | 10 | 2025 | 35875 | 0.200 |
Why?
| | Mammography | 1 | 2024 | 166 | 0.190 |
Why?
| | Graft Occlusion, Vascular | 1 | 2023 | 42 | 0.190 |
Why?
| | Vascular Patency | 1 | 2023 | 121 | 0.190 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 248 | 0.190 |
Why?
| | Iliac Aneurysm | 1 | 2022 | 19 | 0.190 |
Why?
| | Vascular Calcification | 1 | 2024 | 110 | 0.190 |
Why?
| | Robotic Surgical Procedures | 1 | 2025 | 182 | 0.190 |
Why?
| | Enoxaparin | 1 | 2023 | 67 | 0.190 |
Why?
| | Arteries | 1 | 2023 | 259 | 0.180 |
Why?
| | Patients | 1 | 2023 | 180 | 0.180 |
Why?
| | Dyslipidemias | 1 | 2023 | 181 | 0.180 |
Why?
| | Root Cause Analysis | 1 | 2021 | 9 | 0.180 |
Why?
| | Surgical Procedures, Operative | 1 | 2024 | 270 | 0.170 |
Why?
| | Human Rights | 1 | 2021 | 20 | 0.170 |
Why?
| | Aged, 80 and over | 3 | 2024 | 8265 | 0.170 |
Why?
| | Specialties, Surgical | 1 | 2022 | 82 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 405 | 0.160 |
Why?
| | Burns, Electric | 1 | 2020 | 26 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2022 | 168 | 0.160 |
Why?
| | Health Plan Implementation | 1 | 2021 | 136 | 0.160 |
Why?
| | Embolization, Therapeutic | 1 | 2022 | 242 | 0.160 |
Why?
| | Cultural Diversity | 1 | 2021 | 87 | 0.160 |
Why?
| | Communication | 2 | 2023 | 965 | 0.160 |
Why?
| | Morbidity | 1 | 2021 | 323 | 0.150 |
Why?
| | Iatrogenic Disease | 1 | 2020 | 76 | 0.150 |
Why?
| | Quality of Life | 2 | 2022 | 3185 | 0.150 |
Why?
| | Atherosclerosis | 1 | 2023 | 409 | 0.150 |
Why?
| | Societies, Medical | 1 | 2023 | 887 | 0.150 |
Why?
| | Foot | 1 | 2020 | 100 | 0.150 |
Why?
| | Intermittent Claudication | 1 | 2020 | 121 | 0.150 |
Why?
| | Ischemia | 1 | 2022 | 421 | 0.140 |
Why?
| | Tendons | 1 | 2020 | 129 | 0.140 |
Why?
| | Hyoid Bone | 1 | 2018 | 3 | 0.140 |
Why?
| | Aspirin | 1 | 2022 | 399 | 0.140 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 19 | 0.140 |
Why?
| | Current Procedural Terminology | 1 | 2018 | 19 | 0.140 |
Why?
| | Infection Control | 1 | 2020 | 172 | 0.140 |
Why?
| | Nerve Compression Syndromes | 1 | 2018 | 22 | 0.140 |
Why?
| | Femoral Vein | 1 | 2018 | 38 | 0.140 |
Why?
| | Intracranial Embolism | 1 | 2018 | 34 | 0.140 |
Why?
| | Catheterization, Central Venous | 1 | 2020 | 122 | 0.140 |
Why?
| | Carotid Artery Injuries | 1 | 2018 | 39 | 0.140 |
Why?
| | General Surgery | 1 | 2021 | 207 | 0.140 |
Why?
| | Hematoma | 1 | 2018 | 59 | 0.140 |
Why?
| | Urban Health Services | 1 | 2018 | 70 | 0.140 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 280 | 0.140 |
Why?
| | Carotid Artery Diseases | 1 | 2018 | 69 | 0.140 |
Why?
| | Colonic Neoplasms | 1 | 2020 | 259 | 0.140 |
Why?
| | Academic Medical Centers | 1 | 2021 | 547 | 0.140 |
Why?
| | Aged | 6 | 2025 | 25913 | 0.140 |
Why?
| | Laparoscopy | 1 | 2022 | 475 | 0.130 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 497 | 0.130 |
Why?
| | Vena Cava, Inferior | 1 | 2018 | 81 | 0.130 |
Why?
| | Muscle Weakness | 1 | 2018 | 92 | 0.130 |
Why?
| | Vena Cava Filters | 1 | 2018 | 64 | 0.130 |
Why?
| | Vascular System Injuries | 1 | 2018 | 77 | 0.130 |
Why?
| | Running | 1 | 2020 | 228 | 0.130 |
Why?
| | Global Health | 1 | 2021 | 401 | 0.130 |
Why?
| | Colorado | 2 | 2018 | 4564 | 0.130 |
Why?
| | Patient Reported Outcome Measures | 1 | 2021 | 488 | 0.130 |
Why?
| | Rural Health Services | 1 | 2018 | 141 | 0.130 |
Why?
| | Program Evaluation | 1 | 2021 | 948 | 0.130 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 299 | 0.120 |
Why?
| | Anticoagulants | 1 | 2022 | 722 | 0.120 |
Why?
| | Postoperative Complications | 3 | 2025 | 2919 | 0.120 |
Why?
| | Venous Thrombosis | 1 | 2018 | 194 | 0.120 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 732 | 0.120 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 112 | 0.120 |
Why?
| | Comorbidity | 1 | 2021 | 1658 | 0.120 |
Why?
| | Alarmins | 1 | 2015 | 27 | 0.110 |
Why?
| | Mesentery | 1 | 2015 | 45 | 0.110 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 634 | 0.110 |
Why?
| | Electrical Equipment and Supplies | 1 | 2015 | 9 | 0.110 |
Why?
| | Bacterial Translocation | 1 | 2015 | 52 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Hypertension | 1 | 2023 | 1263 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1098 | 0.110 |
Why?
| | Equipment Failure | 1 | 2015 | 115 | 0.110 |
Why?
| | Adult | 6 | 2025 | 40449 | 0.110 |
Why?
| | Lower Extremity | 1 | 2018 | 438 | 0.100 |
Why?
| | Delivery of Health Care | 1 | 2021 | 947 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 2020 | 780 | 0.100 |
Why?
| | Intraoperative Complications | 1 | 2015 | 155 | 0.100 |
Why?
| | Practice Guidelines as Topic | 1 | 2021 | 1560 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 262 | 0.100 |
Why?
| | Telemedicine | 1 | 2022 | 945 | 0.090 |
Why?
| | Liver | 1 | 2020 | 1887 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2168 | 0.080 |
Why?
| | Internship and Residency | 1 | 2021 | 1257 | 0.080 |
Why?
| | Burns | 1 | 2015 | 377 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 1 | 2015 | 2527 | 0.080 |
Why?
| | Incidence | 1 | 2016 | 2879 | 0.080 |
Why?
| | Treatment Failure | 2 | 2022 | 365 | 0.080 |
Why?
| | Computed Tomography Angiography | 2 | 2018 | 145 | 0.060 |
Why?
| | Operative Time | 1 | 2025 | 175 | 0.050 |
Why?
| | Patient Portals | 1 | 2024 | 49 | 0.050 |
Why?
| | Patient Navigation | 1 | 2024 | 104 | 0.050 |
Why?
| | Acute Disease | 1 | 2025 | 1030 | 0.050 |
Why?
| | Ligaments | 1 | 2022 | 75 | 0.040 |
Why?
| | Heparin | 1 | 2023 | 244 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2023 | 268 | 0.040 |
Why?
| | Abdominal Pain | 1 | 2022 | 146 | 0.040 |
Why?
| | Arginase | 1 | 2020 | 27 | 0.040 |
Why?
| | Patient Participation | 1 | 2024 | 431 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 433 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2020 | 251 | 0.040 |
Why?
| | Tenotomy | 1 | 2020 | 22 | 0.040 |
Why?
| | Tendon Transfer | 1 | 2020 | 24 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 1095 | 0.040 |
Why?
| | Aorta | 1 | 2022 | 429 | 0.040 |
Why?
| | Macrophage Activation | 1 | 2020 | 193 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2020 | 116 | 0.040 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2018 | 40 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2021 | 335 | 0.040 |
Why?
| | Retroperitoneal Space | 1 | 2018 | 18 | 0.040 |
Why?
| | Phlebography | 1 | 2018 | 39 | 0.040 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2018 | 37 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2020 | 539 | 0.040 |
Why?
| | Physical Endurance | 1 | 2020 | 278 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 297 | 0.040 |
Why?
| | Head Movements | 1 | 2018 | 36 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 2018 | 119 | 0.030 |
Why?
| | Patient Positioning | 1 | 2018 | 70 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2020 | 557 | 0.030 |
Why?
| | Blood Vessel Prosthesis | 1 | 2018 | 140 | 0.030 |
Why?
| | Cryopreservation | 1 | 2018 | 110 | 0.030 |
Why?
| | Animals | 2 | 2020 | 38058 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 154 | 0.030 |
Why?
| | Device Removal | 1 | 2018 | 143 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 371 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2021 | 704 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 842 | 0.030 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 557 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1720 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2925 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 707 | 0.030 |
Why?
| | Qualitative Research | 1 | 2023 | 1671 | 0.030 |
Why?
| | Reoperation | 1 | 2018 | 630 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1135 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2015 | 203 | 0.030 |
Why?
| | Palliative Care | 1 | 2022 | 1002 | 0.030 |
Why?
| | Fires | 1 | 2015 | 87 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1185 | 0.020 |
Why?
| | Adolescent | 2 | 2025 | 22428 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2847 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1414 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2020 | 3540 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4557 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5992 | 0.020 |
Why?
| | Infant | 1 | 2023 | 10034 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5868 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 14105 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 5226 | 0.020 |
Why?
| | Child | 1 | 2023 | 22633 | 0.010 |
Why?
| | Mice | 1 | 2020 | 18339 | 0.010 |
Why?
|
|
Yi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|